{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:46:16Z","timestamp":1780321576331,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.advms.2013.08.001","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T03:35:33Z","timestamp":1395459333000},"page":"68-73","source":"Crossref","is-referenced-by-count":23,"title":["Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension"],"prefix":"10.1016","volume":"59","author":[{"given":"Aleksandra","family":"Baszczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Musialik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Kopczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Thielemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Kopczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"K\u0119sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Dopiera\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"September (4)","key":"10.1016\/j.advms.2013.08.001_bib0005","first-page":"350","article-title":"Nadci\u015bnienie t\u0119tnicze. Rys historyczny","volume":"11","author":"Januszewicz","year":"2007","journal-title":"Nadcis T\u0119tn."},{"issue":"October (10)","key":"10.1016\/j.advms.2013.08.001_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjhyper.2004.06.001","article-title":"Racial\/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA)","volume":"17","author":"Kramer","year":"2004","journal-title":"Am J Hypertens"},{"issue":"December (6)","key":"10.1016\/j.advms.2013.08.001_bib0015","first-page":"783","article-title":"Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension","volume":"3","year":"2007","journal-title":"Vasc Health Risk Manag."},{"issue":"June (2)","key":"10.1016\/j.advms.2013.08.001_bib0020","first-page":"106","article-title":"Hyperhomocysteinemia\u2013znaczenie w chorobach sercowo-naczyniowych","volume":"6","author":"Piechota","year":"2007","journal-title":"Kadiol Dypl"},{"issue":"April (4)","key":"10.1016\/j.advms.2013.08.001_bib0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.ejcn.1602097","article-title":"Prevalences of hyperhomocysteinemia, unfortunable cholesterol profile and hypertension in European populations","volume":"59","author":"de Bree","year":"2005","journal-title":"Eur J Clin Nutr"},{"issue":"December (2)","key":"10.1016\/j.advms.2013.08.001_bib0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2004.07.020","article-title":"Homocysteine as a risk for coronary heart disease and its association with inflammatory biomarkers, lipids and dietary factors","volume":"177","author":"Shai","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.advms.2013.08.001_bib0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European concerted action project","volume":"June (277)","author":"Graham","year":"1997","journal-title":"JAMA"},{"issue":"April (2)","key":"10.1016\/j.advms.2013.08.001_bib0040","first-page":"75","article-title":"Podwy\u017cszone st\u0119\u017cenie homocysteiny w osoczu jako czynnik ryzyka nadci\u015bnienia t\u0119tniczego","volume":"6","author":"K\u0105dziela","year":"2002","journal-title":"Nadcis T\u0119tn."},{"issue":"December (6)","key":"10.1016\/j.advms.2013.08.001_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00149831-200512000-00005","article-title":"New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers","volume":"12","author":"O\u2019Callaghan","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"April (2)","key":"10.1016\/j.advms.2013.08.001_bib0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HJR.0b013e32831e1185","article-title":"Homocysteine increases the risk associate with hyperlipidaemia","volume":"16","author":"Daly","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"February (2)","key":"10.1016\/j.advms.2013.08.001_bib0055","first-page":"115","article-title":"Hyperhomocysteinemia in patients with primary hypertension","volume":"17","author":"Kopczy\u0144ski","year":"2004","journal-title":"Ann UMCS Sect DDD"},{"issue":"December (Suppl. 1)","key":"10.1016\/j.advms.2013.08.001_bib0060","first-page":"199","article-title":"Evaluation of homocysteine in obese patients with hypertension","volume":"12","author":"Bogda\u0144ski","year":"2011","journal-title":"Obes Rev"},{"issue":"October (16)","key":"10.1016\/j.advms.2013.08.001_bib0065","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","journal-title":"JAMA"},{"issue":"September\u2013October (2)","key":"10.1016\/j.advms.2013.08.001_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0021-9150(75)90004-0","article-title":"Homocysteine theory of arteriosclerosis","volume":"22","author":"McCully","year":"1975","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.advms.2013.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from meta-analysis","volume":"November (325)","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"April (8)","key":"10.1016\/j.advms.2013.08.001_bib0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","article-title":"Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention","volume":"158","author":"Wald","year":"1998","journal-title":"Arch Intern Med"},{"issue":"October (10)","key":"10.1016\/j.advms.2013.08.001_bib0085","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.ATV.17.10.1947","article-title":"Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial","volume":"17","author":"Evans","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"January","key":"10.1016\/j.advms.2013.08.001_bib0090","first-page":"6","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to recent clinical trials","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"issue":"September","key":"10.1016\/j.advms.2013.08.001_bib0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.CIR.96.6.1745","article-title":"High homocysteine levels are independently related to isolated systolic hypertension in older adults","volume":"96","author":"Sutton-Tyrrell","year":"1997","journal-title":"Circulation"},{"issue":"January","key":"10.1016\/j.advms.2013.08.001_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0895-7061(99)00138-7","article-title":"Plasma homocysteine concentration and insulin sensitivity in hypertensive subjects","volume":"13","author":"Sheu","year":"2000","journal-title":"Am J Hypertens"},{"issue":"October (5)","key":"10.1016\/j.advms.2013.08.001_bib0105","first-page":"601","article-title":"Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature","volume":"48","author":"Asfar","year":"2007","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"February (2)","key":"10.1016\/j.advms.2013.08.001_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","article-title":"Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study","volume":"67","author":"Nyg\u00e5rd","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"October (10)","key":"10.1016\/j.advms.2013.08.001_bib0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.ejcn.1600468","article-title":"Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over","volume":"51","author":"Bates","year":"1997","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.advms.2013.08.001_bib0120","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/01.ATV.0000035405.16217.86","article-title":"Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques","volume":"November (22)","author":"Burke","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"May (2)","key":"10.1016\/j.advms.2013.08.001_bib0125","first-page":"114","article-title":"Przydano\u015b\u0107 oznacze\u0144 homocysteiny w diagnostyce mia\u017cd\u017cycy naczy\u0144","volume":"11","author":"Kokoci\u0144ska","year":"2005","journal-title":"Acta Angiol"},{"issue":"February (2)","key":"10.1016\/j.advms.2013.08.001_bib0130","first-page":"109","article-title":"St\u0119\u017cenie homocysteiny a charakterystka kliniczna i obraz koronarograficzny u chorych z chorob\u0105 niedokrwienn\u0105 serca","volume":"4","author":"Wilczy\u0144ska","year":"2002","journal-title":"Pol Przegl Kardiol"},{"issue":"August (7)","key":"10.1016\/j.advms.2013.08.001_bib0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"issue":"January (1)","key":"10.1016\/j.advms.2013.08.001_bib0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI118383","article-title":"Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells","volume":"97","author":"Tsai","year":"1996","journal-title":"J Clin Invest"},{"issue":"February","key":"10.1016\/j.advms.2013.08.001_bib0145","doi-asserted-by":"crossref","first-page":"C396","DOI":"10.1152\/ajpcell.1998.274.2.C396","article-title":"Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells","volume":"274","author":"Tyagi","year":"1998","journal-title":"Am J Physiol"},{"issue":"June (3)","key":"10.1016\/j.advms.2013.08.001_bib0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0008-6363(97)00048-5","article-title":"Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors","volume":"34","author":"Jourdheuil-Rahmani","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"November (21)","key":"10.1016\/j.advms.2013.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine","volume":"104","author":"St\u00fchlinger","year":"2001","journal-title":"Circulation"},{"issue":"May (2)","key":"10.1016\/j.advms.2013.08.001_bib0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2005-872401","article-title":"Mechanisms of the atherogenic effects of elevated homocysteine in experimental models","volume":"5","author":"Wilson","year":"2005","journal-title":"Semin Vasc Med"},{"issue":"January","key":"10.1016\/j.advms.2013.08.001_bib0165","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk stratification in hypertension: new insights from the Framingham Study","volume":"13","author":"Kannel","year":"2000","journal-title":"Am J Hypertens"},{"issue":"December (1\u20132)","key":"10.1016\/j.advms.2013.08.001_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0021-9150(93)90175-T","article-title":"Prevalence of coronary heart disease and associated risk factors among elderly Finnishmen in the Seven Countries Study","volume":"104","author":"Tervahauta","year":"1993","journal-title":"Atherosclerosis"},{"issue":"May (5)","key":"10.1016\/j.advms.2013.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"issue":"October\u2013December (4)","key":"10.1016\/j.advms.2013.08.001_bib0180","first-page":"395","article-title":"Molekularny mechanizm biotoksyczno\u015bci homocysteiny\u2013fakty i hipotezy","volume":"51","author":"Turski","year":"2005","journal-title":"Post Bioch"},{"issue":"July (27)","key":"10.1016\/j.advms.2013.08.001_bib0185","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"issue":"July (7)","key":"10.1016\/j.advms.2013.08.001_bib0190","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0022-2275(20)39141-0","article-title":"Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein","volume":"37","author":"Halvorsen","year":"1996","journal-title":"J Lipid Res"},{"issue":"July (21)","key":"10.1016\/j.advms.2013.08.001_bib0195","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1016\/S0021-9258(18)61082-8","article-title":"The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells","volume":"262","author":"Heinecke","year":"1987","journal-title":"J Biol Chem"},{"issue":"January (1)","key":"10.1016\/j.advms.2013.08.001_bib0200","first-page":"1","article-title":"LDL cholesterol \u2013 new therapeutic possibilities \u2013 how to achieve the target?","volume":"1","author":"Musialik","year":"2010","journal-title":"Forum Zaburze\u0144 Metabolicznych"},{"issue":"February","key":"10.1016\/j.advms.2013.08.001_bib0205","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-depended human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J Biol Chem"},{"issue":"September","key":"10.1016\/j.advms.2013.08.001_bib0210","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases high-density lipoprotein by inhibiting apolipoprotein A-I synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ Res"},{"issue":"February (2)","key":"10.1016\/j.advms.2013.08.001_bib0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2010.11.031","article-title":"Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population","volume":"214","author":"Gu\u00e9ant-Rodriguez","year":"2011","journal-title":"Atherosclerosis"},{"issue":"June (11)","key":"10.1016\/j.advms.2013.08.001_bib0220","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:54:51Z","timestamp":1648670091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112614000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1896112614000200"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2013.08.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}